EP3137118 - METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.11.2022 Database last updated on 07.06.2024 | |
Former | Examination is in progress Status updated on 02.03.2019 | ||
Former | Request for examination was made Status updated on 03.02.2017 | ||
Former | The international publication has been made Status updated on 28.11.2016 | Most recent event Tooltip | 11.11.2022 | Application deemed to be withdrawn | published on 14.12.2022 [2022/50] | Applicant(s) | For all designated states Phio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 / US | [2019/04] |
Former [2017/10] | For all designated states RXi Pharmaceuticals Corporation 257 Simarano Drive, Suite 101 Marlborough, MA 01752 / US | Inventor(s) | 01 /
BYRNE, Michael 8 Loker Street Natick, MA 01760 / US | 02 /
PAVCO, Pamela, A. 822 Plateau Road Longmont, CO 80504 / US | 03 /
BULOCK, Karen, G. 44 Park Street Mendon, MA 01756 / US | [2017/10] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
Former [2017/10] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | Application number, filing date | 15785216.1 | 01.05.2015 | [2017/10] | WO2015US28860 | Priority number, date | US201461987418P | 01.05.2014 Original published format: US 201461987418 P | [2017/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015168605 | Date: | 05.11.2015 | Language: | EN | [2015/44] | Type: | A1 Application with search report | No.: | EP3137118 | Date: | 08.03.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.11.2015 takes the place of the publication of the European patent application. | [2017/10] | Search report(s) | International search report - published on: | US | 05.11.2015 | (Supplementary) European search report - dispatched on: | EP | 25.10.2017 | Classification | IPC: | C12N15/113, A61K48/00, C07H21/02 | [2021/48] | CPC: |
C12N15/1137 (EP,US);
A61K31/7088 (US);
A61P27/02 (EP);
A61P27/04 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/22 (EP);
A61P43/00 (EP);
C12N15/1136 (EP,US);
C12N2310/11 (EP,US);
C12N2310/14 (EP,US);
C12N2310/315 (EP,US);
C12N2310/321 (EP);
C12N2310/322 (EP);
C12N2310/34 (EP);
C12N2310/346 (EP,US);
C12N2310/351 (EP,US);
C12N2310/3515 (EP,US);
C12N2310/3521 (EP);
C12N2310/3533 (EP);
| C-Set: |
C12N2310/321, C12N2310/3521 (EP,US);
C12N2310/322, C12N2310/3533 (US,EP) |
Former IPC [2017/47] | A61K48/00, C07H21/02, C12N15/113 | ||
Former IPC [2017/10] | A61K48/00, C07H21/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/10] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON STÖRUNGEN VOR DEM AUGE UNTER VERWENDUNG VON NUKLEINSÄUREMOLEKÜLEN | [2017/10] | English: | METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULES | [2017/10] | French: | MÉTHODES DESTINÉES À TRAITER LES TROUBLES AFFECTANT L'AVANT DE L' IL FAISANT APPEL À DES MOLÉCULES D'ACIDE NUCLÉIQUE | [2017/10] | Entry into regional phase | 28.11.2016 | National basic fee paid | 28.11.2016 | Search fee paid | 28.11.2016 | Designation fee(s) paid | 28.11.2016 | Examination fee paid | Examination procedure | 28.11.2016 | Examination requested [2017/10] | 28.11.2016 | Date on which the examining division has become responsible | 17.05.2018 | Amendment by applicant (claims and/or description) | 06.03.2019 | Despatch of a communication from the examining division (Time limit: M06) | 09.09.2019 | Reply to a communication from the examining division | 17.04.2020 | Despatch of a communication from the examining division (Time limit: M04) | 20.08.2020 | Reply to a communication from the examining division | 25.02.2022 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2022 | Application deemed to be withdrawn, date of legal effect [2022/50] | 29.07.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/50] | Fees paid | Renewal fee | 30.05.2017 | Renewal fee patent year 03 | 29.05.2018 | Renewal fee patent year 04 | 28.05.2019 | Renewal fee patent year 05 | 27.05.2020 | Renewal fee patent year 06 | 27.05.2021 | Renewal fee patent year 07 | 27.05.2022 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2010033247 (RXI PHARMACEUTICALS CORP [US], et al) [X] 14 * page 131 - page 133 * * the whole document *[I] 15; | [Y]WO2011119871 (RXI PHRMACEUTICALS CORP [US], et al) [Y] 1,8-13 * the whole document * * claim - *; | [XY] - SRINIWAS SRIRAM ET AL., "Reduction of corneal scarring in rabbits by targeting the TGFB1 pathway with a triple siRNA combination", ADVANCES IN BIOSCIENCE AND BIOTECHNOLOGY, (20130101), vol. 04, no. 10, doi:10.4236/abb.2013.410A4005, ISSN 2156-8456, pages 47 - 55, XP055414374 [X] 2,4-7 * the whole document * [Y] 1,8-13 DOI: http://dx.doi.org/10.4236/abb.2013.410A4005 | [A] - SRINIWAS SRIRAM ET AL., "Triple combination of siRNAs Targeting TGF[beta]1, TGF[beta]R2, and CTGF enhances reduction of Collagen I and smooth muscle Actin in corneal fibroblasts", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20131217), vol. 54, no. 13, doi:10.1167/iovs.13-12758, ISSN 1552-5783, page 8214, XP055414366 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1167/iovs.13-12758 | [A] - HAO J. ET AL., "Gene delivery to cornea", BRAIN RESEARCH BULLETIN, ELSEVIER SCIENCE LTD, OXFORD, GB, vol. 81, no. 2-3, ISSN 0361-9230, (20100215), pages 256 - 261, (20090626), XP026825915 [A] 3-5 * the whole document * | [A] - HAO J. ET AL., "Electrically assisted delivery of macromolecules into the corneal epithelium", EXPERIMENTAL EYE RESEARCH, ACADEMIC PRESS LTD, LONDON, vol. 89, no. 6, doi:10.1016/J.EXER.2009.08.001, ISSN 0014-4835, (20091201), pages 934 - 941, (20090812), XP026747515 [A] 3-5 * the whole document * DOI: http://dx.doi.org/10.1016/j.exer.2009.08.001 | [X] - TETSUYA TOYONO ET AL., "Angiopoietin-Like Protein 2 is a potent hemangiogenic and lymphangiogenic factor in corneal inflammation", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20130625), vol. 54, no. 6, doi:10.1167/iovs.12-11497, ISSN 1552-5783, page 4278, XP055414354 [X] 2,3,5,6 * the whole document * DOI: http://dx.doi.org/10.1167/iovs.12-11497 | [X] - HUI GUO ET AL, "Toll-like receptor 2 siRNA suppresses corneal inflammation and attenuates Aspergillus fumigatus keratitis in rats", IMMUNOLOGY AND CELL BIOLOGY, AU, (20110607), vol. 90, no. 3, doi:10.1038/icb.2011.49, ISSN 0818-9641, pages 352 - 357, XP055414709 [X] 2,3,5 * the whole document * DOI: http://dx.doi.org/10.1038/icb.2011.49 | [X] - LI Z. ET AL., "A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis", EMBASE, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, (20140101), Database accession no. EMB-2015893176, XP002774576 [X] 2,4,5 * the whole document * | [X] - LI Z. ET AL., "A new approach of delivering siRNA to the cornea and its application for inhibiting herpes simplex keratitis", CURRENT MOLECULAR MEDICINE 20140101 BENTHAM SCIENCE PUBLISHERS B.V. NLD, (20140101), vol. 14, no. 9, ISSN 1566-5240, pages 1215 - 1225 [X] 2,4,5 | International search | [A]US2012004045 (RENTZ FELTON [US], et al) [A] 1-4* ; abstract *; | [X]US2013131142 (LIBERTINE LYN [US], et al) [X] 1-4 * ; abstract; paragraphs [0007], [0008], [0047], [0056], [0248], [0349], [0363], [0365] * | by applicant | US4201860 | US4235871 | US4501728 | US4737323 | US4810646 | US4837028 | US4853386 | US4897355 | WO9014074 | US4992540 | US5013830 | US5028703 | US5032401 | WO9116024 | WO9117424 | US5082936 | WO9203464 | WO9203568 | US5214135 | US5264423 | US5276019 | US5322841 | US5401727 | US5414077 | US5419966 | WO9523162 | US5504079 | US5512667 | US5525719 | US5580972 | US5587469 | US5591843 | US5607677 | US5646126 | US5652359 | WO9813526 | US5736392 | US5767099 | US5777153 | US5780053 | US5789416 | US5830653 | US5830430 | US5849902 | US5851548 | US5855910 | US5968811 | US6020483 | US6242594 | US6331313 | WO0212348 | US6355787 | US6432963 | US6444448 | US6476003 | US2003157030 | US2003216346 | US2004014715 | US2004063654 | US2004072785 | WO2004065601 | US2004162235 | US2005026286 | US2005037496 | US2005042227 | US2005064595 | US2005107325 | US2005265957 | US2005281781 | US2006008910 | WO2006007372 | US7041824 | US2006178327 | US2006240093 | US7205297 | WO2007050643 | US2007231392 | US2008038296 | WO2008021157 | WO2008036825 | US2008107694 | AU2004206255B | US2008112916 | US2008152661 | WO2009021157 | WO2009102427 | WO2009126933 | WO2009134487 | US2010010082 | US2010040656 | WO2010033247 | US2011039914 | US2012040459 | US2013131142 | US8796443 | - SRIRAM et al., Advances in Bioscience and Biotechnology,, (20130000), vol. 4, no. 10, pages 47 - 55 | - ZUKER, M., Nucleic Acids Res., (20030000), vol. 31, no. 13, pages 3406 - 15 | - MATHEWS, D. H.SABINA, J.ZUKER, M.TURNER, D. H., J. Mol. Biol., (19990000), vol. 288, pages 911 - 940 | - MATHEWS, D. H.DISNEY, M. D.CHILDS, J. L.SCHROEDER, S. J.ZUKER, M.TURNER, D. H., Proc. Natl. Acad. Sci., (20040000), vol. 101, pages 7287 - 7292 | - DUAN, S.MATHEWS, D. H.TURNER, D. H., Biochemistry, (20060000), vol. 45, pages 9819 - 9832 | - WUCHTY, S.FONTANA, W.HOFACKER, I. L.SCHUSTER, P., Biopolymers, (19990000), vol. 49, pages 145 - 165 | - AUGUSTYNS, K. et al., Nucl. Acids. Res., (19920000), vol. 18, page 4711 | - ORTIAGAO et al., Antisense Res. Dev., (19920000), vol. 2, page 129 | - LIANG et al., Pharmazie, (19990000), vol. 54, pages 559 - 566 | - BJERGARDE et al., Nucleic Acids Res., (19910000), vol. 19, page 5843 | - CARUTHERS et al., Nucleosides Nucleotides, (19910000), vol. 10, page 47 | - STEC et al., J. Am. Chem. Soc., (19840000), vol. 106, page 6077 | - STEC et al., J. Org. Chem., (19850000), vol. 50, page 3908 | - STEC et al., J. Chromatog., (19850000), vol. 326, page 263 | - LAPLANCHE et al., Nucl. Acid. Res., (19860000), vol. 14, page 9081 | - BARTZATT, R. et al., Biotechnol. Appl. Biochem., (19890000), vol. 11, page 133 | - LAMONE, Biochem. Soc. Trans., (19930000), vol. 21, page 1 | - KAWASAKI et al., J. Med. Chem., (19930000), vol. 36, page 831 | - UHLMANN et al., Chemical Reviews, (19900000), vol. 90, pages 543 - 584 | - SONVEAUX, "Protecting Groups in Oligonucleotide Synthesis", Agrawal. Methods in Molecular Biology, (19940000), vol. 26, page 1 | - MCNEAL et al., J. Am. Chem. Soc., (19820000), vol. 104, page 976 | - VIARI et al., Biomed. Environ. Mass Spectrom., (19870000), vol. 14, page 83 | - GROTJAHN et al., Nuc. Acid Res., (19820000), vol. 10, page 4671 | - BERGOTEGAN, J. Chrom., (19920000), vol. 599, page 35 | - DNA Cloning, (19850000), vol. I and II | - T. FISHER et al., Nucleic Acids Research, (19930000), vol. 21, page 3857 | - SHI, Y., Trends Genet, (20030100), vol. 19, page 9 | - REICHHART J M et al., Genesis., (20020000), vol. 34, no. 1-2, page 1604 | - SUI et al., Proc. Natl. Acad Sci. USA, (20020000), vol. 99, page 5515 | - WAGNER E. et al., Proc. Natl. Acad. Sci., (19920000), vol. 88, page 4255 | - SOTOOSTROFF, Bioconjug Chem, (20080000), vol. 19, no. 4, pages 840 - 8 | - "Oral Macrophage Mediated Gene Delivery System", SOTOOSTROFF, Nanotech, (20070000), vol. 2, pages 378 - 381 | - LI et al., "Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways", Clinical Immunology, (20070000), vol. 124, no. 2, doi:10.1016/j.clim.2007.05.002, pages 170 - 181, XP022156792 DOI: http://dx.doi.org/10.1016/j.clim.2007.05.002 | - VLASSOV et al., Biochimica et Biophysica Acta, (19940000), vol. 1197, pages 95 - 108 | - LEWIS et al., Proc. Natl. Acad. Sci. USA, (19960000), vol. 93, page 3176 | - HOPE et al., Molecular Membrane Biology, (19980000), vol. 15, page 1 | - KAMATA et al., Nucl. Acids. Res., (19940000), vol. 22, page 536 | - LEWIS et al., Proc. Natl. Acad. Sci., (19960000), vol. 93, page 3176 | - MURPHY et al., Proc. Natl. Acad. Sci., (19980000), vol. 95, page 1517 | - ZUCKERMANN, R. N. et al., J. Am. Chem. Soc., (19920000), vol. 114, page 10646 | - ZUCKERMANN, R. N. et al., Int. J. Peptide Protein Res., (19920000), vol. 40, page 497 | - HUNAG et al., Chemistry and Biology, (19980000), vol. 5, page 345 | - LEWIS et al., Proc. Natl. Acad. Sci. US.A., (19960000), vol. 93, page 3176 | - POOGA et al., Nature Biotechnology, (19980000), vol. 16, page 857 | - DEROSSI et al., Trends in Cell Biology., (19980000), vol. 8, page 84 | - ELLIOTTO'HARE, Cell, (19970000), vol. 88, page 223 | - PROCHIANTZ, A., Curr. Opin. Neurobiol., (19960000), vol. 6, page 629 | - DEROSSI et al., Trends Cell Biol., (19980000), vol. 8, page 84 | - TROY et al., J. Neurosci., (19960000), vol. 16, page 253 | - VIVES et al., J. Biol. Chem., (19970000), vol. 272, page 16010 | - PROCHIANTZ., Current Opinion in Neurobiol., (19960000), vol. 6, page 629 | - ALLINQUANT et al., J Cell Biol., (19950000), vol. 128, page 919 | - SMITH et al., Biochem J, (19910000), vol. 276, pages 417 - 2 | - BUNNELL et al., Somatic Cell and Molecular Genetics, (19920000), vol. 18, page 559 | - GINOBBI et al., Anticancer Res., (19970000), vol. 17, page 29 | - CONSTANTINIDES et al., Pharmaceutical Research, (19940000), vol. 11, page 1385 | - HO et al., J. Pharm. Sci., (19960000), vol. 85, pages 138 - 143 | - M. Y. CHIANG et al., JBiol Chem., (19910000), vol. 266, pages 18162 - 71 | - CHEN et al., J. Biol. Chem., vol. 271, page 28259 | - GOULD, S. J.SUBRAMANI, S., Anal. Biochem., (19880000), vol. 7, pages 404 - 408 | - GORMAN C. M.MOFFAT, L. F.HOWARD, B. H., Mol. Cell. Biol., (19820000), vol. 2, pages 1044 - 1051 | - SELDEN, R.BURKE-HOWIE, K.ROWE, M. E.GOODMAN, H. M.MOORE, D. D., Mol. Cell, Biol., (19860000), vol. 6, pages 3173 - 3179 | - KARLINALTSCHUL, Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 2264 - 68 | - KARLINALTSCHUL, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 77 | - ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 10 | US20110613106 | US19610611996 | WO2009US00852 | WO2009US05247 | WO2009US05251 | WO2009US06211 |